Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$27,125,111
+$6,690,581 QoQ
Shares Held
22,615
+1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#755
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestcor Inc holds $147,490,942 across 10 Drug Manufacturers - General names. LLY ranks #2 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,882 | $43,652,871 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
22,615 | $27,125,111 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
169,809 | $21,453,669 | |
| 4 | MRK |
Merck & Co., Inc.
|
147,382 | $18,938,587 | |
| 5 | ABBV |
AbbVie Inc.
|
71,946 | $18,104,491 | |
| 6 | OGN |
Organon & Co.
|
406,752 | $5,507,422 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
80,237 | $4,623,255 | |
| 8 | AMGN |
Amgen Inc
|
12,724 | $4,607,614 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,125,111 | 22,615 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $20,434,530 | 22,217 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $25,196,949 | 23,446 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $21,919,464 | 28,728 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,337,063 | 32,503 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $31,629,049 | 38,296 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $35,329,808 | 45,764 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $41,967,863 | 47,371 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $44,080,236 | 48,687 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $56,150,040 | 72,176 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $47,815,761 | 82,028 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,745,750 | 85,167 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,237,745 | 90,063 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $34,466,661 | 100,363 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,837,338 | 78,825 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $26,882,348 | 83,137 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $27,107,573 | 83,606 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,482,622 | 78,509 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,713,127 | 89,469 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $21,928,031 | 94,906 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,145,466 | 96,486 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,655,984 | 94,508 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,030,513 | 94,945 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,251,069 | 96,278 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,056,311 | 97,797 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $12,974,342 | 93,529 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||